These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 20090125)
1. Universal access to HIV/AIDS treatment: challenges ahead. Satyanarayana K; Srivastava S Indian J Med Res; 2009 Dec; 130(6):671-4. PubMed ID: 20090125 [No Abstract] [Full Text] [Related]
2. Improving access to essential drugs for people living with HIV/AIDS. Balasubramaniam K Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335 [No Abstract] [Full Text] [Related]
3. Access to treatment for HIV/AIDS: a human rights issue in the developing world. Joni J Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296 [No Abstract] [Full Text] [Related]
5. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity. Berger JM Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292 [No Abstract] [Full Text] [Related]
6. Essential AIDS medications in India. Thomas J Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350 [No Abstract] [Full Text] [Related]
7. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime. Halliburton M Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158 [TBL] [Abstract][Full Text] [Related]
8. Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm. Moatti JP; N'Doye I; Hammer SM; Hale P; Kazatchkine M Nat Med; 2003 Dec; 9(12):1449-52. PubMed ID: 14647513 [No Abstract] [Full Text] [Related]
9. Ensuring access to essential medicines: some economic considerations. Maskus KE Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162 [No Abstract] [Full Text] [Related]
10. Update of the drug resistance mutations in HIV-1: 2004. Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709 [No Abstract] [Full Text] [Related]
11. India: New patent law may restrict access to HIV/AIDS treatments. Cruess G HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971 [TBL] [Abstract][Full Text] [Related]
12. HIV/AIDS in China. A new treatment campaign, but with limited weapons. Cohen J Science; 2004 Jun; 304(5676):1433. PubMed ID: 15178778 [No Abstract] [Full Text] [Related]
13. Clinical data marshalled to treat HIV. Clarke T Nature; 2003 Jun; 423(6942):791. PubMed ID: 12815390 [No Abstract] [Full Text] [Related]
14. Affordable drug access for developing countries. Highleyman L BETA; 2001; 14(2):12-25. PubMed ID: 11785481 [No Abstract] [Full Text] [Related]
15. Antiretroviral resistance in the developing world. Pillay D J HIV Ther; 2007 Dec; 12(4):95-6. PubMed ID: 18578091 [No Abstract] [Full Text] [Related]
16. Balancing pills and patents: intellectual property and the HIV/AIDS crisis. Nderitu T E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022 [No Abstract] [Full Text] [Related]
17. Commentary: the reality of treating HIV and AIDS in poor countries. Sykes R BMJ; 2002 Jan; 324(7331):216-7. PubMed ID: 11831203 [No Abstract] [Full Text] [Related]
18. US Senator calls for bill to increase access to HIV/AIDS medication. Hemsley A Pharm Pat Anal; 2012 Jul; 1(3):238-9. PubMed ID: 24386665 [No Abstract] [Full Text] [Related]
19. Accrued HIV evidence turns treatment dogma on its head. Check E Nature; 2003 Aug; 424(6951):866. PubMed ID: 12931150 [No Abstract] [Full Text] [Related]
20. AIDS and property rights in Africa. Trotter G Health Care Ethics USA; 2001; 9(2):E2. PubMed ID: 16184688 [No Abstract] [Full Text] [Related] [Next] [New Search]